glp 1 for metabolic syndrome Mechanism by which excessive circulating levels of GLP-1 may lead to insulin resistance and syndrome. GLP-1, glucagon-like peptide-1 Current Status of Glucagon-like Peptide-1
Description
Konstantinos Spaniolas, director of the Stony Brook Bariatric and Metabolic Weight Loss Center

The current evidence is promising but incomplete

Xu, G., Stoffers, D

Adv Exp Med Biol

Wegovy works by mimicking the function of a hormone in your body that regulates appetite and food intake
Tirzepatide (Mounjaro and Zepbound) The tirzepatide label uses nearly identical language
